Five major elements of the new health care reform in 2022

One is to continue to deepen the reform of the review and approval system, and accelerate the listing of innovative drugs with clinical value. Last year, it was "continue to promote the priority review and approval of drugs, accelerate the listing of innovative drugs and drugs with urgent clinical needs", but this year a new task has been added, that is, to continue to promote the consistency evaluation of the quality and efficacy of generic drugs.

The second is about basic drugs, there are two things to focus on, one is the adjustment of the basic drug catalog, and the other is the use of basic drugs policy.

On the adjustment of the list of essential drugs, this year's task is to "optimize the national essential drugs list and improve the list management mechanism." Last year, it was "to study the revision of the national essential drugs directory management methods, optimize the directory selection and adjustment procedures, and start the directory adjustment work in due course." From the basic drug catalog adjustment "progress", this year seems to be further.

About the use of basic drugs, this year proposed to "improve the public medical institutions to give priority to the use of basic drugs policy, encouraging the city medical group, county medical **** body, etc. to establish a drug linkage management mechanism, to promote the upper and lower levels of health care institutions to use medication convergence." Last year, it was requested to "strengthen the standardized management of the provision and use of basic drugs and promote the convergence of medication within the medical consortium." From the medication convergence strength, it seems to be a little bigger, but these words are also old words. However, it is worth noting that this year's new proposed "improve the comprehensive clinical evaluation of drugs working mechanism and standard norms, evaluation results as a medical institution drug directory selection, up and down the interface of drugs and other important basis." It seems to give a channel for "the connection of the upper and lower levels of drugs".

Third, on solving the problem of drug shortages, this year proposed to "improve the coordinated monitoring mechanism for medicines, and strengthen the graded response to drug shortages. Strengthen the small varieties of drugs (shortage of drugs) centralized production base construction. Strengthen the protection of drugs for rare diseases." Last year, it was requested to "improve the mechanism for guaranteeing the supply and stabilizing the price of drugs in short supply. Strengthen the supply of medicines for children." It seems that the "way" some more, but for this chronic disease so do in the end, perhaps still an unknown.

Fourth, this year's new proposal to "categorize and promote the implementation of the unique identification of medical devices, to deepen the unique identification in the regulatory, medical, health insurance and other areas of convergence and application." Obviously on the one hand with the State Council Decree No. 739 issued and since June 1, 2021 will come into force "supervision and management of medical devices regulations (2021 Revision)", on the other hand, is also adapted to the collection of supplies.

Fifth, the new "explore and improve the new mode of drug distribution".

Not mentioned again is the "development of medical institutions drug management approach". This article was a key task last year, but to this day do not see. From the National Health Commission's official website on February 9, 2022, posted a "reply to the fourth session of the 13th National People's Congress, Proposal No. 3812" letter, at present, the Commission led the drafting of the "medical institutions drug management approach" is in the discussion stage.

Legal basis

"The Chinese people's **** and the State social insurance law in its entirety" Article 24 The State to establish and improve the new rural cooperative medical system. The administrative methods of the new rural cooperative medical care shall be prescribed by the State Council.

Article 25 of the Full Text of the Social Insurance Law of the People's Republic of China

The State establishes and improves the basic medical insurance system for urban residents. Basic medical insurance for urban residents is a combination of individual contributions and government subsidies. The government shall subsidize the portion of individual contributions required by people enjoying the minimum subsistence guarantee, persons with disabilities who have lost the ability to work, and elderly persons aged sixty years or over and minors from low-income families.